STUDY OBSERVATIONAL OF ERLOTINIB AS SECOND LINE TREATMENT IN PATIENTS WITH SQUAMOUS NSCLC AND EGFR NATIVE
Clinical trial NCT02328391 · UNKNOWN
Trial details
- NCT number
- NCT02328391
- Sponsor
- Grupo Gallego de Cancer de Pulmon
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2013-09-01
- Primary completion
- 2015-03-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.